China’s COVID-19 vaccine enters phase 3 trial
BEIJING, Jun 25 (APP): China reached an important new level of vaccine development with the start of the phase three clinical trial of an inactivated vaccine candidate against COVID-19 in the United Arab Emirates.
It is the first vaccine of its kind to reach a late-stage, mass-scale human trial, according to China National Biotec Group, China Daily reported on Thursday.
- Read more about China’s COVID-19 vaccine enters phase 3 trial
- Log in or register to post comments